Abiopharma

Director SHALLCROSS STEVEN A 🟢 acquired 475.0K shares (1 derivative) of Theriva Biologics, Inc. (TOVX) at $0.24 Transaction Date: Jan 05, 2026 | Filing ID: 001388

📋 MPM BioVentures 2014, L.P. (Shareholder) plans to sell 199K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $128K) Filed: Jan 06, 2026 | ID: 000949

LEWIS JOEL 🟡 adjusted position in 84.0K shares (1 derivative) of GALECTIN THERAPEUTICS INC (GALT) at $4.20 Transaction Date: Jan 02, 2026 | Filing ID: 000008

(99% Neutral) STAAR SURGICAL CO (STAA) Announces Business Combination

(99% Neutral) Westlake Corporation (WLK) Files Form 8-K

Director Diaz Allene M. 🔴 sold 9.8K shares (6 derivative) of Mersana Therapeutics, Inc. (MRSN) at $458.25 ($1.3M) Transaction Date: Jan 06, 2026 | Filing ID: 001385

Director Secor Thomas N 🟡 adjusted position in 1.8K shares (2 derivative) of NOVANTA INC (NOVT) Transaction Date: Jan 02, 2026 | Filing ID: 000014

📋 MPM Oncology Innovations Fund, L.P. (Shareholder) plans to sell 44K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $28K) Filed: Jan 06, 2026 | ID: 000948

Director MONAHAN JOHN J 🟢 acquired 75.0K shares (1 derivative) of Theriva Biologics, Inc. (TOVX) at $0.24 Transaction Date: Jan 05, 2026 | Filing ID: 001384

CALLICUTT JACK W 🟡 adjusted position in 60.0K shares (1 derivative) of GALECTIN THERAPEUTICS INC (GALT) at $4.20 Transaction Date: Jan 02, 2026 | Filing ID: 000006

📋 NOUGUES MAXIMO F (Officer) plans to sell 5K shares of PUMA BIOTECHNOLOGY, INC. (at $5.84 each, total $27K) Filed: Jan 06, 2026 | ID: 000171

New Form 424B3 - Minerva Neurosciences, Inc. Filed: 2026-01-06 AccNo: 0001193125-26-004684 Size: 233 KB

Burns Kristie 🔴 sold 5.1K shares of TACTILE SYSTEMS TECHNOLOGY INC (TCMD) at $28.85 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director Kraws Jeffrey J 🟢 acquired 75.0K shares (1 derivative) of Theriva Biologics, Inc. (TOVX) at $0.24 Transaction Date: Jan 05, 2026 | Filing ID: 001383

Director Dere Willard H 🔴 sold 13.6K shares (12 derivative) of Mersana Therapeutics, Inc. (MRSN) at $572.50 ($1.8M) Transaction Date: Jan 06, 2026 | Filing ID: 001382